471 related articles for article (PubMed ID: 26256004)
1. FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.
Maiese K
Curr Neurovasc Res; 2015; 12(4):404-13. PubMed ID: 26256004
[TBL] [Abstract][Full Text] [Related]
2. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
Maiese K
Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
[TBL] [Abstract][Full Text] [Related]
3. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
Maiese K
Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
Maiese K
Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
[TBL] [Abstract][Full Text] [Related]
5. FoxO proteins in the nervous system.
Maiese K
Anal Cell Pathol (Amst); 2015; 2015():569392. PubMed ID: 26171319
[TBL] [Abstract][Full Text] [Related]
6. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
7. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
8. New Insights for Oxidative Stress and Diabetes Mellitus.
Maiese K
Oxid Med Cell Longev; 2015; 2015():875961. PubMed ID: 26064426
[TBL] [Abstract][Full Text] [Related]
9. Programming apoptosis and autophagy with novel approaches for diabetes mellitus.
Maiese K
Curr Neurovasc Res; 2015; 12(2):173-88. PubMed ID: 25742566
[TBL] [Abstract][Full Text] [Related]
10. The "O" class: crafting clinical care with FoxO transcription factors.
Maiese K; Chong ZZ; Hou J; Shang YC
Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
[TBL] [Abstract][Full Text] [Related]
11. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
Maiese K
J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
[TBL] [Abstract][Full Text] [Related]
12. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
13. FoxO integration of insulin signaling with glucose and lipid metabolism.
Lee S; Dong HH
J Endocrinol; 2017 May; 233(2):R67-R79. PubMed ID: 28213398
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and diabetes mellitus.
Maiese K
World J Diabetes; 2015 Oct; 6(14):1259-73. PubMed ID: 26516410
[TBL] [Abstract][Full Text] [Related]
15. FOXO Signaling Pathways as Therapeutic Targets in Cancer.
Farhan M; Wang H; Gaur U; Little PJ; Xu J; Zheng W
Int J Biol Sci; 2017; 13(7):815-827. PubMed ID: 28808415
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box o as a sensor, mediator, and regulator of redox signaling.
de Keizer PL; Burgering BM; Dansen TB
Antioxid Redox Signal; 2011 Mar; 14(6):1093-106. PubMed ID: 20626320
[TBL] [Abstract][Full Text] [Related]
17. A "FOXO" in sight: targeting Foxo proteins from conception to cancer.
Maiese K; Chong ZZ; Shang YC; Hou J
Med Res Rev; 2009 May; 29(3):395-418. PubMed ID: 18985696
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of FOXO transcription factors in pancreatic beta cells.
Glauser DA; Schlegel W
J Endocrinol; 2007 May; 193(2):195-207. PubMed ID: 17470511
[TBL] [Abstract][Full Text] [Related]
19. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
[TBL] [Abstract][Full Text] [Related]
20. Redox regulation of FoxO transcription factors.
Klotz LO; Sánchez-Ramos C; Prieto-Arroyo I; Urbánek P; Steinbrenner H; Monsalve M
Redox Biol; 2015 Dec; 6():51-72. PubMed ID: 26184557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]